Leerink Partnrs Has Weak Estimate for CVS Health Q1 Earnings

CVS Health Co. (NYSE:CVS) – Equities research analysts at Leerink Partnrs reduced their Q1 2025 earnings per share (EPS) estimates for CVS Health in a report issued on Wednesday, November 6th. Leerink Partnrs analyst M. Cherny now forecasts that the pharmacy operator will post earnings per share of $1.41 for the quarter, down from their previous forecast of $1.49. The consensus estimate for CVS Health’s current full-year earnings is $6.18 per share. Leerink Partnrs also issued estimates for CVS Health’s Q2 2025 earnings at $1.64 EPS, Q4 2025 earnings at $1.68 EPS and FY2025 earnings at $6.65 EPS.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same period last year, the company earned $2.21 earnings per share. The company’s revenue was up 6.3% on a year-over-year basis.

Several other equities research analysts also recently commented on the company. Barclays reduced their price objective on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a report on Thursday. Evercore ISI lifted their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft reduced their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a report on Tuesday, October 1st. Finally, Wells Fargo & Company reduced their price objective on CVS Health from $61.00 to $60.00 and set an “equal weight” rating for the company in a report on Monday, November 4th. Nine research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $73.00.

CVS Health Price Performance

Shares of NYSE:CVS opened at $55.56 on Friday. CVS Health has a 1-year low of $52.77 and a 1-year high of $83.25. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.66. The business has a fifty day moving average price of $59.56 and a 200-day moving average price of $59.19. The company has a market capitalization of $69.89 billion, a PE ratio of 14.10, a PEG ratio of 0.94 and a beta of 0.55.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.79%. CVS Health’s payout ratio is currently 67.51%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. MidAtlantic Capital Management Inc. bought a new stake in CVS Health during the 3rd quarter valued at approximately $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health during the 3rd quarter valued at approximately $31,000. Crewe Advisors LLC bought a new stake in CVS Health during the 1st quarter valued at approximately $40,000. Reston Wealth Management LLC bought a new stake in CVS Health during the 3rd quarter valued at approximately $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new stake in CVS Health during the 3rd quarter valued at approximately $33,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.